Just for all the doubting Thomas's16 Jul 2021 16:23
Here is and excerpt from one of the reports liked on here earlier regarding the poc:
The project was completed on time, and the results mirrored the company’s initial positive results from April. According to the study, SDC-1801 reduced the levels of cytokines linked to ARDS in human lung cells infected with SARS-CoV-2 and had a profile that was superior to the anti-inflammatory steroid dexamethasone and likebaricitinib, a JAK1/JAK2 inhibitor.
That's why those who are in the know are so positive ... And this is just one of the reasons ... To echo the obvious"I wouldn't want to be out of this one over the weekend" ... Mafuta